PAVmed Inc. (ticker: PAVM) is an NASDAQ-listed clinical biotech company. DredgeCap's structured extraction of PAVM's SEC filings surfaces 11 active risk signals, including 7 late-filing signals, 3 delisting/deregistration signals, and 1 auditor-change signal. PAVM reported $22K in revenue and -$60K for the period ending 2026-03-31, with operating cash flow of -$2.62M. Cash and equivalents stood at $6.46M. Total assets of $45.42M exceed total liabilities of $20.43M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
PAVM Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for PAVmed Inc. (PAVM) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.